Considering the dual effects of immunomodulatory factors, chemokines, and their receptors on tumor progression,32, 58, 59 additional in vitro and in vivo studies are necessary to investigate the underlying mechanism linking TIMP3 to the immune environment and clinical prognosis. Here, TIMP3 is linked to neoplasm.